Mounjaro 2.5 mg 1 pen
Eli Lilly
Eli Lilly
Overview
Mounjaro 2.5 mg is a single-use injection pen containing tirzepatide, a dual GIP/GLP-1 receptor agonist used in managing type 2 diabetes, supplied as one pen per pack.
Key Benefits
Helps improve blood glucose control in adults with type 2 diabetes, used alone or together with other antihyperglycemic medicines. May support weight reduction and overall metabolic health as part of a treatment plan.
How to Use
Administered by subcutaneous injection once weekly, into the abdomen, thigh, or upper arm. The starting dose is 2.5 mg per week, with gradual increases to 5-15 mg based on tolerance and clinical response, as directed by your physician.
Active Ingredients
Tirzepatide 2.5 mg per dose.
Precautions
Not for use in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, or those with known hypersensitivity to tirzepatide. Requires monitoring for pancreatitis signs; not recommended for type 1 diabetes or diabetic ketoacidosis. Use under strict medical supervision.
Storage
Store as directed on the pen packaging, protected from light and out of reach of children.